Wanda Filer, MD, MBA, FAAFP, discusses the prevalence of RSV.
Considerations for the Management of Respiratory Syncytial Virus (RSV)
Wanda Filer, MD, MBA, FAAFP, provides an overview of the potential outcomes for patients of all ages with RSV.
Dr Filer highlights the considerations for the rollout of new RSV vaccines.
Financial burden associated with RSV treatment is explored by a medical expert.
In her closing thoughts, Dr Filer provides insights into the unmet needs in the treatment of RSV.
Advertisement
Advertisement
Trending on AJMC
1
Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues
2
FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer
3
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma
4
AI Chatbots Score Below 28% on Colorectal Cancer Questions
5